An intrabody specific for the nucleophosmin carboxy-terminal mutant and fused to a nuclear localization sequence binds its antigen but fails to relocate it in the nucleus-Reference-Cited by-同舟云学术

An intrabody specific for the nucleophosmin carboxy-terminal mutant and fused to a nuclear localization sequence binds its antigen but fails to relocate it in the nucleus

Published:2014-09 Issue: Volume:3 Page:27-33
ISSN:2215-017X
Container-title:Biotechnology Reports
language:en
Short-container-title:Biotechnology Reports

Author:

Martinelli Chiara,Colombo Emanuela,Piccini Daniele,Sironi Cristina,Pelicci Pier Giuseppe,de Marco Ario

Funder

AIRC (Associazione Italiana per la Ricerca sul Cancro)

Publisher

Elsevier BV

Subject

Applied Microbiology and Biotechnology,Biotechnology

Reference42 articles.

1. Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing;Tarapore;FEBS Lett.,2006

2. Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation;Lindstrom;J. Biol. Chem.,2008

3. Nucleophosmin deposition during mRNA 3′ end processing influences poly(A) tail length;Sagawa;EMBO J.,2011

4. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation;Kurki;Cancer Cell,2004

5. Nucleophosmin is required for DNA integrity and p19Arf protein stability;Colombo;Mol. Cell. Biol.,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies;Molecular Therapy - Methods & Clinical Development;2023-12

2. The acidic stretch and the C-terminal nuclear export signal motif of NPM1 mutant: are they druggable in AML?;Leukemia;2023-09-22

3. Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology;BioDrugs;2020-04-16

4. Signaling Landscape of AML: The Story So Far;Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs;2018

5. Use of Single-Chain Antibody Derivatives for Targeted Drug Delivery;Molecular Medicine;2016-01